Drug Profile
Research programme: alprazolam transdermal gel - Antares
Alternative Names: AP-1002; AP-1022Latest Information Update: 26 May 2022
Price :
$50
*
At a glance
- Originator Antares Pharma
- Class Antiepileptic drugs; Anxiolytics; Azoles; Benzodiazepines; Hypnosedatives; Small molecules
- Mechanism of Action GABA B receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 24 May 2022 Antares Pharma has been acquired by Halozyme Therapeutics
- 23 Mar 2007 Preclinical development is ongoing
- 30 Jun 2005 Preclinical trials in Anxiety disorders in USA (Transdermal)